|
Market Closed -
NYSE
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 2.690 USD | -0.37% |
|
+1.89% | +49.44% |
| Market Cap | 217M 189M 178M 162M 303M 20.78B 304M 2.13B 824M 10.57B 814M 796M 34B | P/E 2026 * |
11.2x | P/E 2027 * | 53.8x |
|---|---|---|---|---|---|
| Enterprise Value | 217M 189M 178M 162M 303M 20.78B 304M 2.13B 824M 10.57B 814M 796M 34B | EV / Sales 2026 * |
2.64x | EV / Sales 2027 * | 3.26x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | -0.37% | ||
| 1 week | +1.89% | ||
| Current month | +4.67% | ||
| 1 month | +14.47% | ||
| 3 months | +21.17% | ||
| 6 months | +20.63% | ||
| Current year | +49.44% |
| 1 week | 2.62 |  | 2.79 |
| 1 month | 2.34 | | 2.79 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Free | Director | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.37% | +1.89% | +42.33% | +57.31% | 217M | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | -0.01% | +3.12% | +26.96% | +46.55% | 360.19B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 71.55M 67.53M 61.34M 115M 7.88B 115M 808M 312M 4.01B 309M 302M 12.89B | 66.48M 57.9M 54.64M 49.64M 92.97M 6.37B 93.32M 653M 253M 3.24B 250M 244M 10.43B |
| Net income | 19.63M 17.1M 16.14M 14.66M 27.45M 1.88B 27.56M 193M 74.6M 957M 73.74M 72.1M 3.08B | 3.79M 3.3M 3.12M 2.83M 5.31M 364M 5.33M 37.29M 14.42M 185M 14.25M 13.93M 595M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$2.690 | -0.37% | 1,249,529 |
| 26-09-17 | US$2.700 | +0.75% | 321,894 |
| 26-09-16 | US$2.680 | +0.75% | 1,059,291 |
| 26-09-15 | US$2.660 | -3.97% | 812,742 |
| 26-09-14 | US$2.770 | +4.92% | 952,160 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
